[{"indications": "Indications\u00a0treatment of acute uncomplicated falciparum malaria; treatment of\r\nbenign malaria [unlicensed indication]", "name": "ARTEMETHER WITH LUMEFANTRINE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.4 Antiprotozoal drugs", "5.4.1 Antimalarials", "Artemether with lumefantrine", "ARTEMETHER WITH LUMEFANTRINE"], "cautions": "Cautions\u00a0electrolyte disturbances, concomitant use with other drugs known to cause QT-interval\r\nprolongation; monitor patients unable to\r\ntake food (greater risk of recrudescence); avoid in acute porphyria (section 9.8.2); interactions: Appendix 1 (artemether with lumefantrine)Driving\u00a0Dizziness may affect performance\r\nof skilled tasks (e.g. driving) ", "side-effects": "Side-effects\u00a0abdominal pain, anorexia, diarrhoea, vomiting,\r\nnausea; palpitation, prolonged QT interval; cough; headache, dizziness,\r\nsleep disturbances, asthenia, paraesthesia; arthralgia, myalgia; pruritus,\r\nrash; less commonly ataxia, hypoaesthesia, and clonus", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/106530.htm", "doses": ["Treatment of malaria, see notes above"], "pregnancy": "Pregnancy\u00a0toxicity in animal studies with\r\nartemether; manufacturer advises use only if potential benefit outweighs\r\nrisk"}]